The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease.

MLA

Marius Vögelin, et al. “The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease.” PLoS ONE, vol. 11, no. 5, Jan. 2016, p. e0155218. EBSCOhost, https://doi.org/10.1371/journal.pone.0155218.

APA

Marius Vögelin, Luc Biedermann, Pascal Frei, Stephan R Vavricka, Sylvie Scharl, Jonas Zeitz, Michael C Sulz, Michael Fried, Gerhard Rogler, & Michael Scharl. (2016). The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease. PLoS ONE, 11(5), e0155218. https://doi.org/10.1371/journal.pone.0155218

Chicago

Marius Vögelin, Luc Biedermann, Pascal Frei, Stephan R Vavricka, Sylvie Scharl, Jonas Zeitz, Michael C Sulz, Michael Fried, Gerhard Rogler, and Michael Scharl. 2016. “The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease.” PLoS ONE 11 (5): e0155218. doi:10.1371/journal.pone.0155218.